Literature DB >> 21244468

Serum concentrations of complement anaphylatoxins and proinflammatory mediators in patients with 2009 H1N1 influenza.

Rieko Ohta1, Yuka Torii, Masaki Imai, Hiroshi Kimura, Noriko Okada, Yoshinori Ito.   

Abstract

Anaphylatoxins (C5a, C4a, and C3a) are fragments of activated complement and are leading mediators of the inflammatory response for controlling viral infection. However, an excessive response may increase the severity of infectious diseases. Serum concentrations of proinflammatory mediators, including cytokines, high-mobility group box 1 and anaphylatoxins, were measured in pediatric 2009 H1N1 influenza patients in order to investigate the pathology of this new influenza. The concentrations of all three anaphylatoxins were significantly enhanced by 2009 H1N1 influenza infection. However, there were no significant differences in anaphylatoxin concentrations between 2009 H1N1 influenza patients with and without severe complications during the early stages of the disease. C3a concentrations dropped significantly during the recovery phase, whereas there were no significant differences between the acute and recovery phases in C5a and C4a concentrations. There was a correlation between C5a and IL-2. C4a was associated with IL-1ra, eotaxin, MCP-1, PDGFbb, and VEGF. C3a was correlated with IL-2 and IFN-γ. Taken together, these findings indicate that complement activation occurs in patients infected with 2009 H1N1 influenza virus and demonstrate that anaphylatoxins are involved in increased production of proinflammatory mediators in this new influenza.
© 2011 The Societies and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21244468     DOI: 10.1111/j.1348-0421.2011.00309.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  30 in total

Review 1.  Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design.

Authors:  Sinthujan Jegaskanda; Hillary A Vanderven; Adam K Wheatley; Stephen J Kent
Journal:  Hum Vaccin Immunother       Date:  2017-03-23       Impact factor: 3.452

2.  Distinct cross-reactive B-cell responses to live attenuated and inactivated influenza vaccines.

Authors:  Sanae Sasaki; Tyson H Holmes; Randy A Albrecht; Adolfo García-Sastre; Cornelia L Dekker; Xiao-Song He; Harry B Greenberg
Journal:  J Infect Dis       Date:  2014-03-27       Impact factor: 5.226

3.  Innate immune function and mortality in critically ill children with influenza: a multicenter study.

Authors:  Mark W Hall; Susan M Geyer; Chao-Yu Guo; Angela Panoskaltsis-Mortari; Philippe Jouvet; Jill Ferdinands; David K Shay; Jyotsna Nateri; Kristin Greathouse; Ryan Sullivan; Tram Tran; Shannon Keisling; Adrienne G Randolph
Journal:  Crit Care Med       Date:  2013-01       Impact factor: 7.598

4.  Standard trivalent influenza virus protein vaccination does not prime antibody-dependent cellular cytotoxicity in macaques.

Authors:  Sinthujan Jegaskanda; Thakshila H Amarasena; Karen L Laurie; Hyon-Xhi Tan; Jeff Butler; Matthew S Parsons; Sheilajen Alcantara; Janka Petravic; Miles P Davenport; Aeron C Hurt; Patrick C Reading; Stephen J Kent
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

5.  Fc functional antibodies in humans with severe H7N9 and seasonal influenza.

Authors:  Hillary A Vanderven; Lu Liu; Fernanda Ana-Sosa-Batiz; Thi Ho Nguyen; Yanmin Wan; Bruce Wines; P Mark Hogarth; Danielle Tilmanis; Arnold Reynaldi; Matthew S Parsons; Aeron C Hurt; Miles P Davenport; Tom Kotsimbos; Allen C Cheng; Katherine Kedzierska; Xiaoyan Zhang; Jianqing Xu; Stephen J Kent
Journal:  JCI Insight       Date:  2017-07-06

6.  Anti-Influenza Hyperimmune Immunoglobulin Enhances Fc-Functional Antibody Immunity During Human Influenza Infection.

Authors:  Hillary A Vanderven; Kathleen Wragg; Fernanda Ana-Sosa-Batiz; Anne B Kristensen; Sinthujan Jegaskanda; Adam K Wheatley; Deborah Wentworth; Bruce D Wines; P Mark Hogarth; Steve Rockman; Stephen J Kent
Journal:  J Infect Dis       Date:  2018-09-22       Impact factor: 5.226

Review 7.  The role of C5a in acute lung injury induced by highly pathogenic viral infections.

Authors:  Renxi Wang; He Xiao; Renfeng Guo; Yan Li; Beifen Shen
Journal:  Emerg Microbes Infect       Date:  2015-05-06       Impact factor: 7.163

8.  Complement C5 activation during influenza A infection in mice contributes to neutrophil recruitment and lung injury.

Authors:  Cristiana C Garcia; Wynne Weston-Davies; Remo C Russo; Luciana P Tavares; Milene A Rachid; José C Alves-Filho; Alexandre V Machado; Bernhard Ryffel; Miles A Nunn; Mauro M Teixeira
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

9.  Complement mediated signaling on pulmonary CD103(+) dendritic cells is critical for their migratory function in response to influenza infection.

Authors:  Matheswaran Kandasamy; Poon C Ying; Adrian W S Ho; Hermi R Sumatoh; Andreas Schlitzer; Timothy R Hughes; David M Kemeny; B Paul Morgan; Florent Ginhoux; Baalasubramanian Sivasankar
Journal:  PLoS Pathog       Date:  2013-01-10       Impact factor: 6.823

10.  Elevated Expression Levels of Lung Complement Anaphylatoxin, Neutrophil Chemoattractant Chemokine IL-8, and RANTES in MERS-CoV-Infected Patients: Predictive Biomarkers for Disease Severity and Mortality.

Authors:  Maaweya E Hamed; Asif Naeem; Haitham Alkadi; Aref A Alamri; Ahmad S AlYami; Abdullah AlJuryyan; Wael Alturaiki; Mushira Enani; Samia T Al-Shouli; Abdullah M Assiri; Bandar Alosaimi
Journal:  J Clin Immunol       Date:  2021-07-07       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.